A Sensitive and Cost-Effective Chemiluminescence ELISA for Measurement of Amyloid-ß 1-42 Peptide in Human Plasma.
J Alzheimers Dis
; 78(3): 1237-1244, 2020.
Article
em En
| MEDLINE
| ID: mdl-33252086
ABSTRACT
BACKGROUND:
Amyloid-ß42 (Aß42) is associated with plaque formation in the brain of patients with Alzheimer's disease (AD). Studies have suggested the potential utility of plasma Aß42 levels in the diagnosis, and in longitudinal study of AD pathology. Conventional ELISAs are used to measure Aß42 levels in plasma but are not sensitive enough to quantitate low levels. Although ultrasensitive assays like single molecule array or immunoprecipitation-mass spectrometry have been developed to quantitate plasma Aß42 levels, the high cost of instruments and reagents limit their use.OBJECTIVE:
We hypothesized that a sensitive and cost-effective chemiluminescence (CL) immunoassay could be developed to detect low Aß42 levels in human plasma.METHODS:
We developed a sandwich ELISA using high affinity rabbit monoclonal antibody specific to Aß42. The sensitivity of the assay was increased using CL substrate to quantitate low levels of Aß42 in plasma. We examined the levels in plasma from 13 AD, 25 Down syndrome (DS), and 50 elderly controls.RESULTS:
The measurement range of the assay was 0.25 to 500âpg/ml. The limit of detection was 1âpg/ml. All AD, DS, and 45 of 50 control plasma showed measurable Aß42 levels.CONCLUSION:
This assay detects low levels of Aß42 in plasma and does not need any expensive equipment or reagents. It offers a preferred alternative to ultrasensitive assays. Since the antibodies, peptide, and substrate are commercially available, the assay is well suited for academic or diagnostic laboratories, and has a potential for the diagnosis of AD or in clinical trials.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Fragmentos de Peptídeos
/
Ensaio de Imunoadsorção Enzimática
/
Peptídeos beta-Amiloides
/
Doença de Alzheimer
/
Medições Luminescentes
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article